Log In
BCIQ
Print this Print this
 

Novotarg

  Manage Alerts
Collapse Summary General Information
Company Baliopharm AG
DescriptionBispecific antibody targeting CD 20 and CD 95
Molecular Target CD20 ; Fas receptor (CD95)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today